Clinical Trials Directory

Trials / Conditions / Reversal of Neuromuscular Blockade

Reversal of Neuromuscular Blockade

8 registered clinical trials studyying Reversal of Neuromuscular Blockade — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Single Ascending Dose of HRS-2162 in Healthy Subjects
NCT07195604
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1
Not Yet RecruitingReversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia
NCT07044193
Tamas Vegh, MDPhase 4
Active Not RecruitingReversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia
NCT07044180
Tamas Vegh, MDPhase 4
RecruitingRecovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
NCT06794450
Universitas PadjadjaranPhase 1 / Phase 2
CompletedEfficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
NCT06436768
Beijing Tongren HospitalN/A
Enrolling By InvitationSugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
NCT05887375
University of Missouri-ColumbiaPhase 4
UnknownEvaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection
NCT06246331
Hanlim Pharm. Co., Ltd.—
CompletedSafety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA)
NCT03346057
Merck Sharp & Dohme LLCPhase 4